Sort
85,873 grants matching “alzheimers”
AD R&D Contracts DBSR
$7,429,686National Institute On Aging · Y01 · FY2024 · AG
Open Drug Discovery Center for Alzheimer's Disease
$7,420,073Allan I Levey · Emory University · U54 · FY2020 · AG
Cognitive training to reduce incidence of cognitive impairment in older adults
$7,399,274Jerri Edwards · University Of South Florida · R01 · FY2021 · AG
IUSM Alzheimer's Disease Drug Discovery Center
$7,389,487Alan D. Palkowitz · Indiana University Indianapolis · U54 · FY2022 · AG
Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial
$7,370,815Roberta Diaz Brinton · University Of Arizona · R01 · FY2021 · AG
Unraveling the earliest phases of vascular cognitive impairment and dementia using CADASIL--a monogenic form of small vessel cerebrovascular disease
$7,360,030Jane S Paulsen · University Of Wisconsin-Madison · RF1 · FY2025 · AG
LIPID MAPS
$7,357,278Edward A Dennis · University Of California, San Diego · U54 · FY2006 · GM
Wake Forest Preclinical Imaging and Irradiation Facility
$7,335,679Christopher T Whitlow · Wake Forest University Health Sciences · C06 · FY2020 · OD
LIPID MAPS
$7,316,784University Of California San Diego · U54 · FY2005 · GM
Open Drug Discovery Center for Alzheimer's Disease
$7,311,958Allan I Levey · Emory University · U54 · FY2021 · AG
New Horizons in the Prevention and Treatment of Food Allergy
$7,300,000Robert A Wood · Johns Hopkins University · UM1 · FY2024 · AI
New Horizons in the Prevention and Treatment of Food Allergy
$7,300,000Robert A Wood · Johns Hopkins University · UM1 · FY2025 · AI
IUSM Alzheimer's Disease Drug Discovery Center
$7,297,939Alan D. Palkowitz · Indiana University Indianapolis · U54 · FY2023 · AG
Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial
$7,279,977Roberta Diaz Brinton · University Of Arizona · R01 · FY2023 · AG
Alzheimer's Disease Cooperative Study (ADCS)
$7,233,659Paul S. Aisen · University Of California, San Diego · U01 · FY2010 · AG
Open Drug Discovery Center for Alzheimer's Disease
$7,217,536Allan I Levey · Emory University · U54 · FY2022 · AG
Long-read DNA sequencing of Alzheimers Disease and Related Dementias cases
$7,209,905Andrew Singleton · National Institute On Aging · ZIA · FY2021 · AG
Center for Alzheimer's and Related Dementias (CARD): Collaboration with the Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat)
$7,203,818Andrew Singleton · National Institute On Aging · ZIA · FY2024 · AG
ARIC Neurocognitive Study (ARIC-NCS) Renewal
$7,197,275Josef Coresh · Johns Hopkins University · U01 · FY2022 · HL
Integrative Pathways to Health and Illness
$7,184,584Carol D. Ryff · University Of Wisconsin-Madison · U19 · FY2022 · AG
Exploring Cognitive Aging Using Refernce Ability Neural Networks
$7,180,418Yaakov Stern · Columbia University Health Sciences · RF1 · FY2016 · AG
API A4 Alzheimer's Prevention Trial
$7,162,340Eric M Reiman · Banner Health · R01 · FY2021 · AG
Aging eyes and aging brains in studying alzheimer''s disease: Modern ophthalmic data collection in the adult changes in thought (ACT) study
$7,155,353Cecilia Sungmin Lee · Washington University · R01 · FY2025 · AG
Maintenance and Improvement of NINDS Infrastructure
$7,152,292Rita Devine · National Institute Of Neurological Disorders And Stroke · ZIC · FY2020 · NS
LIPID MAPS
$7,147,392Edward A Dennis · University Of California, San Diego · U54 · FY2007 · GM